Recently, Yuanda Shuyang Pharmaceutical has obtained the GMP certificate issued by the Ministry of Industry and Trade of the Russian Federation. This is the second overseas GMP certificate obtained after the Turkish GMP certificate, indicating that the production and quality management system of Yuanda Shuyang Pharmaceutical's new production base for blood products has been certified by the Pharmaceutical Inspection Co-operation Scheme (PIC/S) and the Eurasian Economic Union (EAEU). This achievement represents a new breakthrough in the company's internationalization strategy.

According to the GMP standards of the Eurasian Economic Union (EAEU), inspectors from the Ministry of Industry and Trade of the Russian Federation conducted a comprehensive inspection of the company's medicinal product quality system, personnel, premises and equipment, documents, production, quality control, outsourcing activities, and self-inspection. With excellent product quality as well as strict production and quality management system, Yuanda Shuyang Pharmaceutical has received recognition and approval from the Russian authority.

Yuanda Shuyang Pharmaceutical has always been committed to the R&D, production, and sale of high-quality medicinal products, earning the trust of global customers with professional technology, excellent management, and high-quality services.  The acquisition of the Russian GMP certificate will further promote the company's business expansion in the Russian and global markets. Yuanda Shuyang Pharmaceutical will take this opportunity to continue to strengthen medicinal product R&D and production management, continually enhance product quality and customer satisfaction, and provide global customers with higher-quality and safer medicinal products.